Evaluation of process control in radiation oncology treatment planning.

Authors

null

Henry Wagner

Penn State Hershey Cancer Institute

Henry Wagner, Maria Singer, Jamie Knipple, Amy Aurand, Paulette Repella, Michele Ferenci

Organizations

Penn State Hershey Cancer Institute

Research Funding

No funding sources reported
Background: ROTP extends from simulation (SIM) through the start of treatment and constitutes a sequence of processes. Accurate implementation of each of these is essential for proper treatment. Prior guidelines had been proposed in our department for conformal treatment and intensity modulated radiation therapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT); these were often not met leading to dissatisfaction by staff and patients. To improve this we evaluated the current steps in ROTP in an effort to improve our process. Methods: We analyzed the records of 157 eligible patients who underwent CT simulation from 1/1/12 through 3/30/12, excluding patients treated for benign disease, brachytherapy, or patients who never started treatment. The departmental standard was for urgent cases to start within 4 days (d), non-IMRT cases to start in 5d and IMRT/VMAT/SBRT cases to start in 10d. We defined three intervals, from SIM to start of treatment, SIM to approval of the plan by the physician, and approval to treatment start. Results: The median interval between planning landmarks in work-days and the % exceeding planning standards plus 2 days are shown below. Almost half of cases exceeded departmental standards for timeliness of ROTP. Much of the variability occurred after the physician had approved the plan. Conclusions: To improve timeliness of ROTP we have introduced changes in our planning process: 1. Strict definition of urgent cases. 2. Assigning a start date at the time of simulation. 3. Case planning review by the Radiation Oncologist, dosimetrist (+/- Physicist) at SIM. 4. Daily review of task list by Chief of Physics and Department Chair. These changes have been implemented in our department and results of the first two months of their use will be presented.
Treatment
type
SIM-START
(days)
SIM-APP
(days)
APP-START
(days)
Allowed
time (days)
% Exceeding
departmental
standard >2 days
Urgent 2 2 1 4d 2/30
3D 9 5 4 7d 48/70
IMRT/VMAT 11 6 7 12d 15/43
SBRT 14 6 8 12d 10/14
All patients 9 4 5 75/157

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2012 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

General Poster Session B

Track

Quality Measurement,Quality Improvement ,The Use of IT to Improve Quality,Involving Patients in Quality Care

Sub Track

Guideline Recommendation Compliance and Its Effects on Quality

Citation

J Clin Oncol 30, 2012 (suppl 34; abstr 186)

DOI

10.1200/jco.2013.31.31_suppl.186

Abstract #

186

Poster Bd #

B12

Abstract Disclosures

Similar Abstracts

First Author: Tingyu WANG

Abstract

2023 ASCO Quality Care Symposium

Understanding radiation treatment terminations as an element of quality.

First Author: William Chun-Ying Chen